Clinical trial
EXIBIT: Oxaliplatin in Biliary Tract Cancer
NCT00174564 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174564 |
|---|---|
| Title | EXIBIT: Oxaliplatin in Biliary Tract Cancer |
| Official title | A Multicentre Phase II Trial of Gemcitabine and Oxaliplatin (GEMOX) in Patients With Biliary Tract Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Biliary Tract Neoplasms |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Enrollment | 67 |
| Start date | Apr 1, 2003 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 17, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: